Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Broggini

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|July 15, 2010
Preclinical colorectal cancer chemopreventive efficacy and p53-modulating activity of 3',4',5'-trimethoxyflavonol, a quercetin analogueLynne M Howells, Robert G Britton, Marco Mazzoletti, et al.
Stem Cells (Dayton, Ohio)|March 24, 2007
Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell markerStefano Zangrossi, Mirko Marabese, Massimo Broggini, et al.
Journal of the National Cancer Institute|March 22, 2014
DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected]Federica Polato, Paolo Rusconi, Stefano Zangrossi, et al.
Cell Cycle (Georgetown, Tex.)|May 1, 2012
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotypeFrancesca Ricci, Sergio Bernasconi, Patrizia Perego, et al.
Journal of Inorganic Biochemistry|September 29, 2012
Serum depletion of holo-ceruloplasmin induced by silver ions in vivo reduces uptake of cisplatinEvgeny A Zatulovskiy, Alexey N Skvortsov, Paolo Rusconi, et al.
Cells|December 11, 2022
NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2)Marika Colombo, Federico Passarelli, Paola A Corsetto, et al.
Growth Factors (Chur, Switzerland)|March 28, 2008
KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/scatter factor in renal tubular cellsTeresa Rampino, Marilena Gregorini, Cristina Guidetti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 28, 2007
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancerMirko Marabese, Sergio Marchini, Eleonora Marrazzo, et al.
Oncotarget|September 11, 2015
Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cellsElisa Caiola, Daniela Salles, Roberta Frapolli, et al.
Molecular Cancer Therapeutics|July 14, 2011
Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cellsKatherine S Lovejoy, Maria Serova, Ivan Bieche, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Cancer Prevention Research (Philadelphia, Pa.)|July 15, 2010
Preclinical colorectal cancer chemopreventive efficacy and p53-modulating activity of 3',4',5'-trimethoxyflavonol, a quercetin analogueLynne M Howells, Robert G Britton, Marco Mazzoletti, et al.
Stem Cells (Dayton, Ohio)|March 24, 2007
Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell markerStefano Zangrossi, Mirko Marabese, Massimo Broggini, et al.
Journal of the National Cancer Institute|March 22, 2014
DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected]Federica Polato, Paolo Rusconi, Stefano Zangrossi, et al.
Cell Cycle (Georgetown, Tex.)|May 1, 2012
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotypeFrancesca Ricci, Sergio Bernasconi, Patrizia Perego, et al.
Journal of Inorganic Biochemistry|September 29, 2012
Serum depletion of holo-ceruloplasmin induced by silver ions in vivo reduces uptake of cisplatinEvgeny A Zatulovskiy, Alexey N Skvortsov, Paolo Rusconi, et al.
Cells|December 11, 2022
NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2)Marika Colombo, Federico Passarelli, Paola A Corsetto, et al.
Growth Factors (Chur, Switzerland)|March 28, 2008
KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/scatter factor in renal tubular cellsTeresa Rampino, Marilena Gregorini, Cristina Guidetti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 28, 2007
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancerMirko Marabese, Sergio Marchini, Eleonora Marrazzo, et al.
Oncotarget|September 11, 2015
Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cellsElisa Caiola, Daniela Salles, Roberta Frapolli, et al.
Molecular Cancer Therapeutics|July 14, 2011
Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cellsKatherine S Lovejoy, Maria Serova, Ivan Bieche, et al.
Pageof 12